Navigation Links
Greenberg Traurig Shareholder Jennifer A. Camacho Selected to Receive Mass High Tech's 2011 All-Stars Award
Date:9/9/2011

BOSTON, Sept. 9, 2011 /PRNewswire/ -- Mass High Tech has selected Greenberg Traurig shareholder Jennifer A. Camacho to be a recipient of its 2011 All-Stars Award, one that recognizes 15 driven and influential leaders of New England's innovation economy.  

Camacho will be recognized for her wide range of experience in and contribution to the life sciences sector.  As a patent attorney, she represents pharmaceutical and biotechnology clients. Camacho brings a real-world perspective to client representation from her tenure as chief patent counsel, vice president of intellectual property and general counsel at a venture-backed start-up company in the emerging field of synthetic biology and DNA synthesis.  She is a founding team member for the International Consortium for Polynucleotide Synthesis, Inc., and currently serves on the board of directors for the Center for Policy on Emerging Technologies in Washington, D.C.  In addition,  Camacho serves as a judge and mentor for the MassChallenge, Inc. annual startup competition and accelerator program.

"The 2011 All-Stars have a proven record in leading not only their own companies but in helping their industry thrive and in guiding entrepreneurs who are building the successful tech companies of tomorrow," said Mass High Tech publisher Doug Banks.  "The companies and industries that they have helped to build are the basis of the economic engine that provides jobs and spawns innovation throughout New England and the United States."

Honorees will be profiled in a special report on MassHighTech.com and recognized at an evening awards celebration and networking reception on Wednesday, November 16th, at the House of Blues in Boston.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP is an international, full-service law firm with approximately 1,800 attorneys serving clients from more than 30 offices in the United States, Europe and Asia. In the U.S., the firm has more offices than any other among the Top 10 on The National Law Journal's 2011 NLJ 250. In the U.K., the firm operates as Greenberg Traurig Maher LLP. Greenberg Traurig has a strategic alliance with the independent law firm, Studio Santa Maria in Milan and Rome. The firm was Chambers and Partners' USA Law Firm of the Year in 2007 and among the Top 3 in the International Law Firm of the Year at the 2009 The Lawyer Awards. For additional information, please visit www.gtlaw.com.


'/>"/>
SOURCE Greenberg Traurig, LLP
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
2. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
3. Mymetics Corporation Important Shareholders Information Conference Call
4. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
5. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
6. Chromos announces shareholder approval of Arrangement
7. Sangui Bio Tech International Inc. Shareholders Meeting Delayed to Include FY 2008 Report
8. ARIUS sale approved by shareholders
9. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
10. China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
11. Insmed to Seek Shareholder Approval for Reverse Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... for their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. ... media products engineered to radically streamline culture processes, minimize processing time, significantly ...
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. (OTCQB: ... company focused on developing and commercializing products to ... medical need, announced today the long-term follow-up data ... (dusquetide), a first-in-class Innate Defense Regulator (IDR), in ... and neck cancer patients undergoing chemoradiation therapy (CRT).  ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016 ... augmentation remediation technologies and selected NewTechBio,s NT-MAX ... a microbial based beneficial bacteria, in conjunction with ... to correct deficiencies with National Pollutant Discharge Elimination ... 281-8H has experienced a steady history of elevated ...
(Date:12/8/2016)... 8, 2016   Biocept, Inc . (NASDAQ: ... of clinically actionable liquid biopsy tests to improve ... data featuring its Target Selectorâ„¢ Circulating Tumor Cell ... the detection of actionable biomarkers in patients with ... by Sara Cannon Research Institute (SCRI), the research ...
Breaking Biology Technology:
(Date:11/28/2016)... "The biometric system market projected to ... system market is in the growth stage and is ... biometric system market is expected to be valued at ... 16.79% between 2016 and 2022. Government initiative in adoption ... rising use of biometric technology in financial institutes and ...
(Date:11/21/2016)... 21, 2016   Neurotechnology , a provider ... today announced that the MegaMatcher On Card fingerprint ... for the NIST Minutiae Interoperability Exchange (MINEX) ... mandatory steps of the evaluation protocol. ... test of fingerprint templates used to establish compliance ...
(Date:11/16/2016)... Calif. , Nov. 16, 2016 ... user experience and security for consumer electronics, and ... the financial and retail industry, today announced a ... and convenient way to authenticate users of mobile ... Sensory,s TrulySecureâ„¢ software which requires no ...
Breaking Biology News(10 mins):